Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 2.730
0.00 (0.00%)
Apr 17, 2026, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 1.35 billion as of April 17, 2026. Its market cap has increased by 80.92% in one year.
Market Cap
1.35B
Enterprise Value
1.41B
Revenue
36.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.73
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 1.35B, a decrease of -83.04%. That is a compound annual growth rate of -25.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 1.35B | 39.29% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 2.11B |
| Frontage Holdings | 2.09B |
| Mabpharm | 1.79B |
| Zhaoke Ophthalmology | 1.76B |
| Cutia Therapeutics | 1.73B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.70B |
| CANbridge Pharmaceuticals | 1.57B |
| Beijing Biostar Pharmaceuticals | 1.40B |